Peculiar clinical and dermoscopic remission pattern following imiquimod therapy of basal cell carcinoma in seborrhoeic areas of the face
Author:
Publisher
Informa UK Limited
Subject
Dermatology
Link
http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883
Reference32 articles.
1. Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential
2. Modulation of TH1 and TH2 Cytokine Production with the Immune Response Modifiers, R-848 and Imiquimod
3. Imiquimod, a Topical Immune Response Modifier, Induces Migration of Langerhans Cells11The authors have declared a conflict of interest.
4. The Immune Response Modifiers Imiquimod and R-848 Are Potent Activators of B Lymphocytes
5. Topical immunomodulators—progress towards treating inflammation, infection, and cancer
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Rare Cutaneous Side Effects of Imiquimod: A Review on Its Mechanisms, Diagnosis, and Management;Dermatology and Therapy;2023-08-01
2. Eruptive Epidermoidzysten nach Imiquimod-Therapie eines rezidivierenden Basalzellkarzinoms;Der Hautarzt;2019-01-29
3. Use of Dermoscopy to Diagnose and Select BCCs that can be Treated Empirically;Current Dermatology Reports;2018-04-13
4. Éruption de kystes épidermiques après application d’imiquimod topique;Annales de Dermatologie et de Vénéréologie;2017-03
5. Applicability of dermoscopy for evaluation of patients' response to nonablative therapies for the treatment of superficial basal cell carcinoma;British Journal of Dermatology;2014-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3